2021
DOI: 10.1016/j.devcel.2021.11.006
|View full text |Cite
|
Sign up to set email alerts
|

Distinct contributions of partial and full EMT to breast cancer malignancy

Abstract: Highlights d Lineage tracing of partial and full EMT cells in breast cancer metastasis d Partial EMT cells cycle between hybrid EMT and epithelial stages d Partial, but not full, EMT cells are required for metastasis formation d Both partial and full EMT cells contribute to chemoresistance Authors Fabiana L€ uo ¨nd, Nami Sugiyama,

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

9
159
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 212 publications
(168 citation statements)
references
References 78 publications
(123 reference statements)
9
159
0
Order By: Relevance
“…In this phase diagram, the IFNγ-induced leftward shift is clearly visible. Additionally, it shows that the total range of SNAIL1 for which the hybrid E/M phenotype, a particularly aggressive EMT phenotype (Lüönd et al, 2021, andreviewed in Jolly, Somarelli, et al, 2018), can (co-)exist is unaffected.…”
Section: Ifnγ Promotes the Occurrence Of Emtmentioning
confidence: 93%
“…In this phase diagram, the IFNγ-induced leftward shift is clearly visible. Additionally, it shows that the total range of SNAIL1 for which the hybrid E/M phenotype, a particularly aggressive EMT phenotype (Lüönd et al, 2021, andreviewed in Jolly, Somarelli, et al, 2018), can (co-)exist is unaffected.…”
Section: Ifnγ Promotes the Occurrence Of Emtmentioning
confidence: 93%
“…An immunofluorescence microscopy assay for cytoskeletal remodeling elements [ 76 ] has been successfully implemented as a readout for EMT disruption to screen a panel of transcription factor-targeting siRNAs to determine transcriptional nodes that control EMT [ 77 ], which can be useful for easy drug treatment and screening for future testable therapeutics targeting EMT. Moreover, recent work has combined fluorescent lineage tracing with intravital live microscopy to visualize and trace early and late EMT states in the primary tumor and metastatic sites, providing a much needed look inside the dynamic processes of tumor progression and EMT [ 13 ]. Combined immunofluorescence with other techniques, such as cell morphology or single-cell segmentation, has distinct advantages over bulk flow or sequencing by maintaining tumor architecture and spatial organization in the tissue.…”
Section: Immunohistochemistry and Fluorescencementioning
confidence: 99%
“…The presence and role of a variety of hybrid EMT states in disease progression and metastasis remains a lynchpin in EMT-based therapies. Current evidence suggests that rather than relying solely on an MET to revert from a fully mesenchymal state, metastasis may result from the high plasticity and adaptability of the intermediate or hybrid states [ 12 , 13 ], as observed by the presence of intermediate circulating tumor cell clusters (CTCs clusters) [ 14 , 15 ]. Regardless of a clear-cut mechanism, which is still currently in debate, the presence of an intermediate state appears to be critical to the formation of metastasis, either through plasticity or as a transitional state.…”
Section: Introductionmentioning
confidence: 99%
“…Cancer cells can also revert from P-EMT states to epithelial states through mesenchymal-epithelial transition (MET) (Beerling et al ., 2016; Jolly et al, 2017; Reichert et al ., 2018). This spectrum of heterogenous EMT states may be associated with differences in epithelial plasticity and cell migration, thereby influencing tumor progression, metastasis and response to treatment (Aiello et al ., 2018; Lüönd et al, 2021). Targetable cell intrinsic mechanisms that drive either P-EMT or C-EMT remain elusive.…”
Section: Introductionmentioning
confidence: 99%